EYPT vs VOO
Eyepoint Pharmaceuticals Inc (EYPT) versus VOO (VOO) — a side-by-side from cached financials, not a winner call.
Eyepoint Pharmaceuticals Inc (EYPT) is a biotechnology company listed on NASDAQ.
VOO (VOO) common stock.
Latest reported EYPT revenue for 2026-06-30 was $1.2M. Net income was -$179.3M. Revenue was up 72.8% from 2026-03-31 to 2026-06-30. EYPT currently screens at market cap $1.10B.
VOO does not have a complete income-statement cache yet.
EYPT currently screens at market cap $1.10B. VOO currently screens at market cap $0.
Not investment advice. Open the EYPT and VOO stock pages for the full models.
Not investment advice.